<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02719223</url>
  </required_header>
  <id_info>
    <org_study_id>0002-16</org_study_id>
    <nct_id>NCT02719223</nct_id>
  </id_info>
  <brief_title>The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension</brief_title>
  <official_title>The Effect of On-Line Hemodiafiltration Versus High Flux Hemodialysis on Hemodynamic Parameters in Patients With Intra-Dialytic Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Galilee Hospital-Nahariya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western Galilee Hospital-Nahariya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale and objectives

        1. Patients on On Line Hemodiafiltration (OL- HDF) are more stable hemodynamically with
           less Intra Dialytic Hypotension (IDH) episodes compared to conventional hemodialysis
           (HD). The investigator will follow the hemodynamic parameters during the dialysis
           sessions (HD and OL-HDF) by using the new non invasive technology, the NICAS device.

        2. By switching each patient with IDH from HD to OL- HDF, the investigators will evaluate
           the hemodynamic parameters and compare the two renal replacement treatment modalities,
           and prove the superiority of OL-HDF over HD regarding the hemodynamic measures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intradialytic hypotension (IDH) or a significant fall in blood pressure (BP) is the most
      common complication that occurs during hemodialysis (HD) treatment, occurring in up to 20-33%
      of sessions.

      Different mechanisms are involved in the pathogenesis of IDH including acute central
      hypovolemia, may be precipitated by rapid or excessive ultrafiltration that lead to
      intravascular volume depletion beyond the level of hemodynamic compensatory response. Other
      proposed mechanisms of intra vascular depletion are volume shift into the extra-vascular
      space due to rapid reduction in plasma osmolality, slow and incompatible vascular refilling
      rate and incorrectly low prescribed dry weight.

      Autonomic dysfunction occurs in considerable amount of dialysis patients up to about 50% .
      This dysfunction reduces the ability to produce an adequate sympathetic response in the
      setting of acute volume diminution.

      Due to the complexity of the dialysis treatment and absence of non- invasive technology, few
      studies followed the hemodynamic changes which occur during a dialysis session especially
      during IDH episodes.

      OL- HDF is a relatively new method of therapy that allows a larger volume of blood filtration
      during a single dialysis therapy compared with standard hemodialysis.

      Compared to conventional HD treatment, OL-HDF treatment was associated with lower incidence
      of IDH and better hemodynamic stability.

      Bioelectrical impedance analysis is a method for estimating body composition in most of the
      cases. The Non-Invasive Cardiac System (NICaS) device (non-invasive cardiac system) applies
      the principle of Whole Body Bio-Impedance and provides continuous data regarding the
      hemodynamic status (i.e. heart rate, stroke volume, cardiac output, cardiac index, and total
      peripheral vascular resistance) as well as respiration rate and total body water.

      Following the hemodynamic changes, the NICaS device will allow to shed light on the
      physiological mechanisms underlying the IDH phenomenon and prove the superiority of OL-HDF
      over regular hemodialysis regarding the hemodynamic measures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The superiority of OL-HDF over regular hemodialysis in decreasing the frequency of intradialytic hypertension episodes.</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean arterial pressure (mm/Hg)</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac index (l/min/m2)</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total peripheral resistance (dynes/sec/cm5)</measure>
    <time_frame>5 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intradialytic Hypotension</condition>
  <arm_group>
    <arm_group_label>High Flux Hemodialysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>OL-HDF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NICaS</intervention_name>
    <description>The NICaS is a non invasive device for measuring and calculating of hemodynamic parameters including mean arterial pressure (mm/Hg), cardiac index (l/min/m2) and total peripheral resistance (dynes/sec/cm5).</description>
    <arm_group_label>High Flux Hemodialysis</arm_group_label>
    <arm_group_label>OL-HDF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients affected by IDH during one or more dialytic sessions every week

        Exclusion Criteria:

          -  Patients with recent change in chronic medications, chronic liver disease, recent
             acute coronary event, cardiac arrhythmias and acute infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rena Borenstein, MS</last_name>
    <email>renab@gmc.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ronit Geron, MD</last_name>
    <email>ronitg@gmc.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Western Galilee Hospital</name>
      <address>
        <city>Nahariya</city>
        <zip>22100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Batya Kristal, MD</last_name>
      <phone>+97249107603</phone>
      <email>batya.kristal@naharia.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Shifra Sela, PhD</last_name>
      <phone>+97249107769</phone>
      <email>shifra.sela@naharia.health.gov.il</email>
    </contact_backup>
    <investigator>
      <last_name>Batya Kristal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001 Oct;38(4 Suppl 4):S11-7. Review.</citation>
    <PMID>11602456</PMID>
  </results_reference>
  <results_reference>
    <citation>K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005 Apr;45(4 Suppl 3):S1-153.</citation>
    <PMID>15806502</PMID>
  </results_reference>
  <results_reference>
    <citation>Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R; Hemodialysis (HEMO) Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19;347(25):2010-9.</citation>
    <PMID>12490682</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011 Aug;22(8):1526-33. doi: 10.1681/ASN.2010101119.</citation>
    <PMID>21803971</PMID>
  </results_reference>
  <results_reference>
    <citation>Ronco C, Brendolan A, Milan M, Rodeghiero MP, Zanella M, La Greca G. Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney Int. 2000 Aug;58(2):800-8.</citation>
    <PMID>10916105</PMID>
  </results_reference>
  <results_reference>
    <citation>Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004 Sep;66(3):1212-20.</citation>
    <PMID>15327420</PMID>
  </results_reference>
  <results_reference>
    <citation>Zoccali C, Benedetto FA, Tripepi G, Mallamaci F. Cardiac consequences of hypertension in hemodialysis patients. Semin Dial. 2004 Jul-Aug;17(4):299-303. Review.</citation>
    <PMID>15250922</PMID>
  </results_reference>
  <results_reference>
    <citation>Caplin B, Kumar S, Davenport A. Patients' perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant. 2011 Aug;26(8):2656-63. doi: 10.1093/ndt/gfq763. Epub 2011 Jan 6.</citation>
    <PMID>21212166</PMID>
  </results_reference>
  <results_reference>
    <citation>Sands JJ, Usvyat LA, Sullivan T, Segal JH, Zabetakis P, Kotanko P, Maddux FW, Diaz-Buxo JA. Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int. 2014 Apr;18(2):415-22. doi: 10.1111/hdi.12138. Epub 2014 Jan 27.</citation>
    <PMID>24467830</PMID>
  </results_reference>
  <results_reference>
    <citation>van der Sande FM, Kooman JP, Leunissen KM. Intradialytic hypotension--new concepts on an old problem. Nephrol Dial Transplant. 2000 Nov;15(11):1746-8. Review.</citation>
    <PMID>11071958</PMID>
  </results_reference>
  <results_reference>
    <citation>Ewing DJ, Winney R. Autonomic function in patients with chronic renal failure on intermittent haemodialysis. Nephron. 1975;15(6):424-9.</citation>
    <PMID>1196462</PMID>
  </results_reference>
  <results_reference>
    <citation>Lilley JJ, Golden J, Stone RA. Adrenergic regulation of blood pressure in chronic renal failure. J Clin Invest. 1976 May;57(5):1190-200.</citation>
    <PMID>1262465</PMID>
  </results_reference>
  <results_reference>
    <citation>Daugirdas JT. Dialysis hypotension: a hemodynamic analysis. Kidney Int. 1991 Feb;39(2):233-46.</citation>
    <PMID>2002637</PMID>
  </results_reference>
  <results_reference>
    <citation>Santoro A. Cardiovascular dialysis instability and convective therapies. Hemodial Int. 2006 Jan;10 Suppl 1:S51-5. Review.</citation>
    <PMID>16441871</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2016</study_first_submitted>
  <study_first_submitted_qc>March 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2016</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intradialytic hypotension</keyword>
  <keyword>hemodynamic parameters</keyword>
  <keyword>Hemodiafiltration</keyword>
  <keyword>NICAS device (non-invasive cardiac system)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

